E71.542 Other group 3 peroxisomal disorders

Name of the Condition

• Other group 3 peroxisomal disorders

Summary

Other group 3 peroxisomal disorders are a subset of genetic conditions affecting peroxisome function, cellular organelles critical for breaking down fatty acids, producing bile acids, and detoxifying harmful substances. These disorders result in metabolic imbalances and neurological issues due to the accumulation of toxic compounds or deficiency of essential metabolites. The specific manifestations depend on the underlying genetic defect and the peroxisomal pathways affected.

Causes

Other group 3 peroxisomal disorders are caused by mutations in genes involved in peroxisome biogenesis or function. These mutations disrupt the organelle's ability to perform its metabolic roles, leading to the buildup of substances like very long-chain fatty acids or the deficiency of plasmalogens, which are critical for brain and lung function. The genetic basis varies, with different mutations affecting peroxisome assembly or enzyme activity.

Risk Factors

• Family history of peroxisomal disorders due to autosomal recessive inheritance.
• Consanguineous relationships (parents who are closely related).

Symptoms

• Developmental delays or regression.
• Muscle weakness or hypotonia.
• Seizures or abnormal eye movements.
• Liver dysfunction or enlarged liver.
• Abnormal facial features in some subtypes.
• Respiratory or feeding difficulties in infancy.

Diagnosis

Diagnosis involves biochemical testing to measure levels of very long-chain fatty acids, plasmalogens, or other peroxisomal metabolites in blood or urine. Genetic testing may confirm specific mutations. Clinical evaluation of physical features and radiographic imaging may also be used to assess organ involvement.

Treatment Options

Treatment is supportive and focuses on managing symptoms. This may include dietary modifications to reduce fatty acid intake, medications to control seizures, and therapies to address developmental delays. Multidisciplinary care involving neurologists, hepatologists, and metabolic specialists is often required.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the disorder and the specific genetic mutation. Some individuals may experience progressive neurological decline, while others have milder symptoms. Regular follow-up with specialists is essential to monitor organ function, adjust treatments, and address complications.

Complications

• Progressive neurological damage.
• Liver failure or cirrhosis.
• Respiratory insufficiency.
• Developmental regression.
• Seizure disorders.

Lifestyle & Prevention

• Genetic counseling for families with a history of peroxisomal disorders.
• Prenatal testing may be considered for at-risk pregnancies.
• Avoiding exposure to substances that may exacerbate metabolic stress.

When to Seek Professional Help

Seek medical attention if symptoms such as developmental delays, seizures, or liver dysfunction appear, especially in infants or young children. Early diagnosis and intervention can improve outcomes.

Tips for Medical Coders

Document the specific clinical manifestations and diagnostic findings to support the use of code E71.542. Ensure that the medical record clearly indicates the presence of a group 3 peroxisomal disorder and any associated complications. Include details about genetic testing or biochemical abnormalities to justify the diagnosis.